Beta-catenin mutations in hepatocellular cancer, tumor cell metabolism, and the response of these tumors to mTOR inhibition.

作者
Satdarshan P. Monga,Mitesh J. Borad,Junyan Tao
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:38 (4_suppl): 583-583 被引量:2
标识
DOI:10.1200/jco.2020.38.4_suppl.583
摘要

583 Background: Hepatocellular cancer (HCC) continues to grow in incidence despite approval of many new therapies including immune checkpoint inhibitors (ICIs) and TKIs. Genomic landscape of HCC is becoming increasing apparent through WGS and WES. One major driver of HCC is the Wnt/b-catenin pathway. Mutations in CTNNB1, which encodes for b-catenin, are evident in 26-37% of all human HCCs. However, expression of mutant-b-catenin in liver in mice is insufficient for HCC development. Indeed, analysis of HCC cases has revealed CTNNB1 mutations to significantly co-exist with other aberrations including activation/overexpression of Met and Myc and mutations in TERT promoter or mutations in NFE2L2/KEAP1, APOB and ARID2. Methods: Using sleeping beauty transposon/transposase and hydrodynamic tail vein injection, we co-expressed mutant-CTNNB1 (S45Y, S33Y or T41A) and one other clinically relevant co-occurrence to study significance and biology of HCC. Any novel findings in the preclinical model were validated in HCC patient cohorts. Results: Co-expression of mutant-CTNNB1 and one relevant co-occurrence led to development of HCC in mice in 6-10 weeks. All HCC in these models showed a dramatic increase in glutamine synthetase (GS), encoded by Glul, a known target of the Wnt/b-catenin signaling pathway in the liver. This led to an increase in glutamine levels in the tumor-bearing livers. Increased glutamine in the tumors in turn led to increased levels of phospho-mTOR-S2448, a marker of mTORC1 activation. In fact, examination of ~400 patient HCCs showed a significant correlation between positive GS and p-mTOR-S2448 staining. Treatment of Met-b-catenin model with Rapamycin led to notable and significant decrease in HCC burden. Conclusions: Our studydemonstrates b-catenin-mutated HCC to be positive for both GS and in turn mTORC1 active. This provides a novel opportunity for personalized medicine in HCC and CTNNB1-mutated HCCs may be vulnerable to therapeutic targeting by mTOR and more specially, mTORC1 inhibitors.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
FF完成签到 ,获得积分10
刚刚
zwt完成签到,获得积分10
刚刚
hupo发布了新的文献求助10
刚刚
强健的面包的应助被xucc采纳,获得50
刚刚
科目三的应助被mkl采纳,获得10
1秒前
1秒前
英俊的铭的应助被Alvin_Bell采纳,获得10
2秒前
LXK发布了新的文献求助100
2秒前
南瓜豆腐完成签到 ,获得积分10
3秒前
SciGPT的应助被阿飞采纳,获得10
4秒前
4秒前
无题完成签到,获得积分10
4秒前
4秒前
4秒前
do0完成签到,获得积分10
4秒前
Elysia完成签到,获得积分10
5秒前
欣喜书兰完成签到 ,获得积分10
5秒前
Somnolence咩完成签到,获得积分10
5秒前
亓雅丽完成签到 ,获得积分10
5秒前
5秒前
DGYT7786完成签到,获得积分10
5秒前
5秒前
JF完成签到,获得积分10
5秒前
luoxiang完成签到,获得积分10
5秒前
Qiao完成签到,获得积分10
6秒前
6秒前
taozhanhua发布了新的文献求助10
6秒前
向日葵完成签到,获得积分10
6秒前
6秒前
Inter09完成签到,获得积分10
6秒前
赘婿的应助被Cc采纳,获得10
6秒前
赘婿的应助被cc采纳,获得10
6秒前
希望天下0贩的0的应助被峥嵘采纳,获得10
7秒前
7秒前
CZ完成签到,获得积分10
7秒前
科研小白完成签到,获得积分10
7秒前
Hello的应助被自由棉花糖采纳,获得10
7秒前
科研通AI6.3的应助被嘿嘿采纳,获得10
7秒前
dis完成签到,获得积分10
7秒前
喜欢不下雨完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185